← Back to Search

Clinician Training Program for Long COVID

N/A
Waitlist Available
Led By Lisa Marie McAndrew, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 3-months
Awards & highlights

Study Summary

This trial tests if a training program can help VA clinicians provide better care to Veterans with Long-COVID, including by engaging in conversations that validate experience, create a shared understanding, and develop an action plan.

Who is the study for?
This trial is for English-speaking VA primary care providers and Veterans with Long-COVID who are receiving care in the VA. Providers must not have prior Concordant Care training, and Veterans need to have an upcoming appointment within 1-6 months after clinician consent.Check my eligibility
What is being tested?
The study tests a Concordant Care training program for clinicians treating Long-COVID. It aims to see if this training helps them engage better with patients by validating experiences, understanding conditions together, and planning patient-centered actions.See study design
What are the potential side effects?
Since the interventions involve educational training rather than medical or pharmaceutical treatments, there are no direct physical side effects expected from participating in this clinical trial.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 3-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 3-months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Concordance of Illness Perceptions Questionnaire Change
Concordant Care Practice Change
Secondary outcome measures
Medical Outcomes Survey Adherence Scale
Patient Satisfaction Questionnaire (PSQ-III)
Veterans Rand (VR-12)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Providers receiving Long-COVID Concordant Care TrainingExperimental Treatment1 Intervention
Providers randomized to this arm will receive concordant care training.
Group II: Providers receiving Education Packet TrainingActive Control1 Intervention
Providers randomized to this arm will receive education packet training

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,085 Total Patients Enrolled
Lisa Marie McAndrew, PhDPrincipal InvestigatorEast Orange Campus of the VA New Jersey Health Care System, East Orange, NJ
2 Previous Clinical Trials
470 Total Patients Enrolled

Media Library

Concordant Care Training Clinical Trial Eligibility Overview. Trial Name: NCT05787379 — N/A
Post-COVID Syndrome Research Study Groups: Providers receiving Long-COVID Concordant Care Training, Providers receiving Education Packet Training
Post-COVID Syndrome Clinical Trial 2023: Concordant Care Training Highlights & Side Effects. Trial Name: NCT05787379 — N/A
Concordant Care Training 2023 Treatment Timeline for Medical Study. Trial Name: NCT05787379 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies for volunteers in this experiment?

"The clinicaltrials.gov page indicates that this medical trial is not currently accepting patients. Although the study was first posted on May 1st, 2023 and last edited on March 23rd, 2023, there are a plethora of other trials with open recruitment at present."

Answered by AI
~232 spots leftby Sep 2027